Skip to main content
SIU Annual Conference Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench-to-Bedside
Bench-to-Bedside
SIU@U
SIU@U
    Session Type: Sponsored Symposium

    Luncheon Symposium: PSMA PET Imaging and Radioligand Therapy in Prostate Cancer – What Urologists Need to Know in 2025

    Thursday, October 30, 2025
    12:45 - 14:00 GMT+0
    Location: Sidlaw, L3

    SIU@U

      Chair(s)

    • Robert Reiter

      Professor of Urology
      University of California Los Angeles, United States

    Learning Objectives :

    At the end of this session, attendees should be able to:
    • Recall the fundamentals of PSMA imaging and radioligand therapy in the contemporary management of prostate cancer.
    • Summarize the basics of PSMA PET/CT imaging acquisition, interpretation, and clinical indications as well as its role in guiding treatment decision-making in the prostate cancer management.
    • Outline the current PSMA-targeted radioligand therapies and supporting clinical evidence in the management of patients with mCRPC.
    • Recognize the role of a multidisciplinary tumour board in guiding the management of patients with advanced prostate cancer in clinical practice.

    Presentations:

    • 12:45 - 12:50 GMT+0
      Welcome and Session Introductions

      Chair: Robert Reiter – University of California Los Angeles

    • 12:50 - 13:05 GMT+0
      PSMA PET Radioligand Imaging

      Speaker: Thomas Langbein – Zentralklinik Bad Berka, Germany

    • 13:05 - 13:20 GMT+0
      PSMA-Targeted Radioligand Therapy

      Speaker: Amit Bahl – University Hospitals Bristol

    • 13:50 - 14:00 GMT+0
      Summary and Q&A

      Chair: Robert Reiter – University of California Los Angeles